Research joint ventures and technological proximity

Müller, Aranja; Zaby, Alexandra

doi:10.1016/j.respol.2018.12.006

Cited by 11 publications

(15 citation statements)

References 36 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In particular, EMFs always tend to focus on incremental changes to absorb and apply existing practices and technologies; they also tend to carry out technological activities in similar fields (Shi et al, 2020). This is because the similar technological portfolios facilitate technological learning (M€ uller and Zaby, 2019). Existing studies merely show the linear or curvilinear relationship between the technological proximity and its outcomes, such as innovation performance, knowledge creation and organizational collaboration Vrande, 2013).…”

Section: Technological Proximity Learning Mechanisms and Capability U...mentioning

confidence: 99%

“…However, learning is not a straightforward process that just involves the transfer of "discrete nuggets of knowledge or technology" from one to another (Wang et al, 2014). Technological proximity can help firms absorb knowledge and develop new recombinations during the learning process (Knoben and Oerlemans, 2006;M€ uller and Zaby, 2019). This is what is required for capability upgrading (Shi et al, 2020).…”

Section: Introductionmentioning

confidence: 99%

“…, 2014). Technological proximity can help firms absorb knowledge and develop new recombinations during the learning process (Knoben and Oerlemans, 2006; Müller and Zaby, 2019). This is what is required for capability upgrading (Shi et al.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Capability upgrading through technological proximity: evidence from a leading Chinese e-bike firm

Zhang

et al. 2022

IJOEM

View full text Add to dashboard Cite

PurposeThe rapid growth of emerging market firms (EMFs) has been a topic of interest for the past two decades, especially in China. However, few studies have discussed how and why EMFs can impel the upgrading of their capabilities to quickly win competitive advantages in the global market. In this context, the purpose of this paper is to unravel the implausible upgrading phenomenon from the perspective of technological proximity.Design/methodology/approachThis paper adopts a single case study, specifically that of a leading Chinese e-bike firm, with a special focus on the dynamic nature of the capability upgrading process and underlying mechanisms.FindingsThe results show that taking advantage of technological proximity is an important way for EMFs to climb the ladder of capability upgrading. The stage-based process reveals how capability upgrading is achieved through elaborate actions related to technological proximity. Furthermore, this study finds three learning mechanisms behind the technological proximity, which enable firms to successfully upgrade to higher levels of capabilities. In particular, the trigger role played by contextual conditions in guiding firms' capability upgrading is highlighted and characterized.Research limitations/implicationsThis study enriches traditional capability upgrading literature from a technological proximity perspective, especially the traditional static upgrading research related to EMFs. The authors also contribute to the conceptualization of technological proximity. However, the research setting is China's e-bike industry; therefore, the study's generalizability to other emerging markets and industries may be limited.Practical implicationsThe results show that it is important to recognize the value of the transfer and sharing of technology between proximal industries for local governments. Also, appropriate policies should be developed to break down the technology barriers between these industries. Moreover, rather than catching up with the superior technologies of multinational corporations in advanced countries, focusing on products with high technological proximity in local or regional areas may be more helpful for EMFs' upgrading.Originality/valueThis paper investigates the capability upgrading process and mechanisms in EMFs, particularly with respect to the role played by technological proximity.

show abstract

Section: Technological Proximity Learning Mechanisms and Capability U...mentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Capability upgrading through technological proximity: evidence from a leading Chinese e-bike firm

Zhang

et al. 2022

IJOEM

View full text Add to dashboard Cite

show abstract

“…Then, the profit allocation mechanisms based on cooperative game theory are used. Müller and Zaby (2019) utilized game theory to determine the best cooperation scenario, including no participation and only competition, no participation in R&D but technology sharing and joint R&D, and each strategy's profit for alliance partners.…”

Section: Cooperative Game Theorymentioning

confidence: 99%

“…Regarding the profit split mechanisms, some points should be mentioned. For a less complicated problem, the game theory approaches such as sequential bargaining models (Yan, 2012;Yan and Yang, 2012), cooperative game theory based on the Shapley value (Sun et al, 2019, Zhang et al, 2019, core concept (Wu et al, 2017;Marzband et al, 2017), and competitive game theory (Müller and Zaby, 2019) could be referred. Moreover, for more complex problems in which the value of coalitions by different players or the value of different strategies of players could not be determined straightforwardly, other logical PAP mechanisms have been applied.…”

Section: Profit Splitmentioning

confidence: 99%

Select issues in designing license contracts of strategic alliances in the pharmaceutical supply chain.

Mostofi¹

View full text Add to dashboard Cite

Pharmaceutical products play an important role in the human life and improvement of patients. There are many types of medicine for which the supply chain networks have been spread around the world. This extensive application and communication in the logistic of pharmaceutical products entail efficient management and coordination of involved partners. Also, many organizations including private and public organizations as well as financial and insurance companies implement the functions of pharmaceutical services in health systems. Effective management of the partners’ relationships in a coordinated and integrated manner requires cooperative strategies. Furthermore, the evaluation of these strategies requires consideration of different aspects of cooperation, the participatory capabilities of partners, and necessary incentives facilitating their participation. In this thesis, the establishment of a strategic alliance, between producers of the new and patented pharmaceutical products by the cooperation of main producers or licensor of medicines by local manufacturers, distributors, pharmacies as well as local government are studied. In this regard, pricing of the patented medicines and valuing the license contract are taken into account by regarding different settings and assumptions surrounded the pharmaceutical supply chain. The problems under consideration can be specifically categorized as profit distribution problems in strategic alliances, especially when the alliance is formed with the participation of international partners. As described later, pricing decisions and mechanisms play a crucial role in identifying cooperative profits. Hence, after providing a deep analysis of the pricing mechanisms of the different pharmaceutical products, the cooperative game theory is utilized to address the profit split decisions of the partners under consideration. In doing so, it is attempted to distribute the profits fairly to partners and provide incentives for the participation of them to so-called coordinate them. The thesis is organized into four sections. The first section discusses a general license contract in the context of an international joint venture where the pricing mechanism of pharmaceutical products is similar to many other products and no special control by the regulatory bodies limits it. In this context, the medicinal raw materials and some medicinal compounds that are supplied in bulk could be mentioned. The results of this section provide managerial insights that could be extended to other special structures of pharmaceutical products and facilitate the extraction of solutions in more complex problems. The complex model of an alliance firm considering the financing issue, the demand and market uncertainty, the competitive pricing mechanism in an oligopoly market, the tax and depreciation issues as well as the possibility of the alliance liquidation is studied in the second section. Also, based on the results of the general model of the license contract in the first section, an innovative algorithm based on dynamic programming is proposed to extract the solution of this multi-period stochastic model. In the third section, the patented medicines are investigated through the establishment of a local manufacturer under a license contract from the main manufacturer. For the patented medicines, also known as branded medicines, the reference-based pricing mechanism is explored. The mechanism is nowadays the most applicable mechanism in many countries as well as the country under study. However, to account for the capabilities of the partners in the cooperative alliance consisting of the main local and main manufacturers as well as the government who affords most of the pharmaceutical-related cost of the patients through franchises themes, the cooperative game theory approach is used to modify the price of medicines produced now domestically. We regard this approach as an innovative pharmaceutical pricing agreement that plays the role of coordinator of partners by ensuring proper distribution of cooperative surplus to them. The final section focuses on the deterioration of pharmaceutical products and the effects that a cooperative alliance similar to the one introduced in the third section has on the reduction of this phenomenon. Indeed, we introduce the domestic production of patented medicines as an efficient strategy that could significantly reduce the deterioration of medicines as one of the most worrying challenges of the pharmaceutical supply chain. For all models discussed in the sections of the thesis, first, the surrounded assumptions of the problem are clarified deeply, and after developing the mathematical models of the problems, the ways for obtaining optimal solutions are explained in detail. Also, the results of the proposed models are compared with the evidence in real-world problems for validation purposes. The thesis ends with managerial insights, conclusions, and future works opportunities in the final section.

show abstract

RETRACTED ARTICLE: A game theory data science-based mechanism for licensed pharmaceutical products concerning their deterioration: a case of a micro, small, and medium enterprise in Iran

et al. 2023

View full text Add to dashboard Cite

One of the main characteristics of health systems and pharmaceutical supply chains is their significant costs in the public sector, which has forced governments and companies active in this field to find ways to reduce costs. In this paper, the deterioration of imported pharmaceutical items is investigated as one of the challenges of the supply chain of pharmaceutical firms. Specifically, the micro, small medium enterprise (MSME), and a collaborative strategy to reduce its costs is presented. The technical solution of the cooperative strategy is the formation of a partnership alliance between the foreign patent holder of brand drugs and a domestic manufacturer through an exclusive license contract in the local country. This leads to a significant reduction of costs in the distribution network of the pharmaceutical supply chain. On the other hand, supply chain management techniques in the cooperative strategy provide the necessary motivation for its practical implementation by splitting fair profits between producers and other members, namely local government, distributors, and pharmacies. For these purposes, a cooperative game theory-based contract is utilized to set the parameters of the license agreement, and then a profit-sharing mechanism is introduced that splits the benefits of cooperation among the supply chain members based on their afforded costs. The most important contribution of the current research is to propose an integrated framework that combines the logistics network models, valuation methods, and profit split mechanisms that embody more facts from real-world problems than separate models in this regard in previous studies. Moreover, results of the proposed strategy in the supply chain of a drug for thalassemia patients in Iran indicate the effectiveness of the proposed strategy in reducing costs and deterioration. Further, it is shown that the higher the ordering costs of the imported drugs, the lower the market share of the patent holder, and the lower the financing expenses of the cooperative alliance, the more efficient is the proposed strategy.

show abstract

Research joint ventures and technological proximity

Cited by 11 publications

References 36 publications

Capability upgrading through technological proximity: evidence from a leading Chinese e-bike firm

Capability upgrading through technological proximity: evidence from a leading Chinese e-bike firm

Select issues in designing license contracts of strategic alliances in the pharmaceutical supply chain.

RETRACTED ARTICLE: A game theory data science-based mechanism for licensed pharmaceutical products concerning their deterioration: a case of a micro, small, and medium enterprise in Iran

Contact Info

Product

Resources

About